StockNews.com initiated coverage on shares of Veradigm (NASDAQ:MDRX – Get Free Report) in a research report issued on Wednesday. The firm set a “hold” rating on the software maker’s stock.
Veradigm Stock Down 3.3 %
Shares of NASDAQ:MDRX opened at $10.39 on Wednesday. Veradigm has a 1 year low of $5.01 and a 1 year high of $11.80. The business’s 50 day moving average price is $9.91 and its 200-day moving average price is $9.70.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in Veradigm stock. Innealta Capital LLC bought a new stake in Veradigm Inc. (NASDAQ:MDRX – Free Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 3,974 shares of the software maker’s stock, valued at approximately $38,000.
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Read More
- Five stocks we like better than Veradigm
- Top Biotech Stocks: Exploring Innovation Opportunities
- Survey Reveals: Which States Saw the Biggest Investment Gains in 2024?
- Buy P&G Now, Before It Sets A New All-Time High
- Amazon’s Healthcare Gamble: A New Era of Medical Disruption
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Semiconductor Giant Synopsys Slides 14% — Time to Take Notice
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
